Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.

scientific article

Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JVI.00135-15
P932PMC publication ID4473576
P698PubMed publication ID25948740

P50authorTetsuro IkegamiQ40311693
Alexander N. FreibergQ93156043
Nandadeva LokugamageQ117812116
Terry L JuelichQ121296446
P2093author name stringLihong Zhang
Bin Gong
Jennifer K Smith
Terence E Hill
Olga A L Slack
Hoai J Ly
P2860cites workThe impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainmentQ26830833
Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouseQ27305612
Complete Genome Analysis of 33 Ecologically and Biologically Diverse Rift Valley Fever Virus Strains Reveals Widespread Virus Movement and Low Genetic Diversity due to Recent Common AncestryQ27478367
Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in KenyaQ27482900
Three-Dimensional Organization of Rift Valley Fever Virus Revealed by Cryoelectron TomographyQ27487138
RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever virusesQ27487321
Single-particle cryo-electron microscopy of Rift Valley fever virusQ27488344
Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNAQ27491320
Bunyaviridae RNA Polymerases (L-Protein) Have an N-Terminal, Influenza-Like Endonuclease Domain, Essential for Viral Cap-Dependent TranscriptionQ27664646
Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virusQ28486276
Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells.Q31149260
TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus.Q33198557
A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells.Q33316823
Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylationQ33406230
Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccinesQ33570326
Challenges and Practices in Building and Implementing Biosafety and Biosecurity Programs to Enable Basic and Translational Research with Select Agents.Q33699916
Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSsQ33705717
Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome systemQ33755025
Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and preventionQ33960690
The pathogenesis of Rift Valley feverQ34191969
Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheepQ34221766
Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infectionQ34260234
NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture.Q35024013
Advances in Rift Valley fever research: insights for disease preventionQ35077969
Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoesQ35097798
Recent weather extremes and impacts on agricultural production and vector-borne disease outbreak patternsQ35128140
Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacyQ35841573
Molecular epidemiology of Rift Valley fever virusQ35849036
Potential effects of Rift Valley fever in the United StatesQ36053652
Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccineQ36131361
NSm protein of Rift Valley fever virus suppresses virus-induced apoptosisQ36315241
Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosisQ36397378
Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strainsQ36414512
Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep.Q36501630
The C-terminal region of Rift Valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts antiapoptotic functionQ36506825
Molecular biology and genetic diversity of Rift Valley fever virusQ36652695
Toscana virus NSs protein promotes degradation of double-stranded RNA-dependent protein kinaseQ36759758
Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in miceQ37006803
Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves.Q37254943
Rift valley fever vaccinesQ37393780
Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIHQ38326807
Genetic variation among geographic isolates of Rift Valley fever virusQ38891360
Rainfall and epizootic Rift Valley fever.Q38963344
NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinaseQ39195523
The Rift Valley fever epizootic in Egypt 1977–1978 1. Description of the epizootic and virological studiesQ39240187
NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62.Q39547955
The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in miceQ39588385
Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSsQ39601913
Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoproteinQ39686341
The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA moleculesQ39870549
NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcriptionQ39960501
Evaluation of lamb and calf responses to Rift Valley fever MP-12 vaccinationQ40206211
Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteinsQ40233812
Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign geneQ40311587
Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccineQ40317212
DC-SIGN as a receptor for phlebovirusesQ40318139
Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virusQ40321756
Genetic evidence for Rift Valley fever outbreaks in Madagascar resulting from virus introductions from the East African mainland rather than enzootic maintenanceQ40327417
The pathogenesis of Rift Valley fever virus in the mouse modelQ40348320
Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimersQ40397884
Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeysQ40557158
Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep.Q40579610
Improved Recovery of Rabies Virus from Cloned cDNA Using a Vaccinia Virus‐Free Reverse Genetics SystemQ40629273
Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience.Q40632227
Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovidsQ40645618
Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattleQ40645625
Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheepQ40753243
Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccineQ40759549
General aspects of the 1987 Rift Valley fever epidemic in MauritaniaQ40779661
Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewesQ40795447
Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine developmentQ40814834
The development of a formalin-killed Rift Valley fever virus vaccine for use in man.Q40987065
Tempering the risk: Rift Valley fever and bioterrorismQ44936397
P433issue14
P407language of work or nameEnglishQ1860
P921main subjectRift Valley feverQ326638
attenuated vaccineQ1810913
Rift Valley fever virusQ14276794
Rift Valley fever phlebovirusQ24809101
P304page(s)7262-7276
P577publication date2015-05-06
P1433published inJournal of VirologyQ1251128
P1476titleRift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments
P478volume89